Live feed
Filing
SC 13G
SC 13G0001214659-14-008583·Astellas Pharma Inc.
Schedule 13G ownership disclosure
Cytokinetics Inc
Security class unavailable · CUSIP: 23282W605
Event date: 2014-12-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,040,816
- Percent of class
- 5.2800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-14-008583
- Form type
- SC 13G
- Filer
- Astellas Pharma Inc.
- CIK
- CIK 1376684
- Filed
- Dec 29, 2014
- Reporting period
- Dec 26, 2014
- Description
- Schedule 13G beneficial ownership